business
Celladon Shutters Its R&D
Celladon Shutters Its R&D
Kerry Grens | Jun 26, 2015
Biotech firm likely to pull the plug after its gene therapy product fails.
Another CAR-T IPO
Another CAR-T IPO
Jef Akst | Apr 6, 2015
Cellectis goes public for a whopping $228 million—nearly double the value the company filed for in February.
Roche Snags Tumor Tester for $1B
Roche Snags Tumor Tester for $1B
Kerry Grens | Jan 13, 2015
The pharmaceutical company bought a majority stake in Foundation Medicine, a firm that develops personalized cancer-medicine diagnostics.
SAIC Founder Dies
SAIC Founder Dies
Kerry Grens | Dec 30, 2014
J. Robert Beyster, who established one of the largest research and engineering firms, passed away at age 90.
Merck Buys Sigma-Aldrich for $17B
Merck Buys Sigma-Aldrich for $17B
Kerry Grens | Sep 22, 2014
Two giants merge as the German drug maker acquires the US-based science supply company.
Keeping Up with IP
Keeping Up with IP
Kate Yandell | Sep 1, 2014
It’s never too early to start thinking about intellectual property rights—even for biologists doing basic research.
Roche Buys Biotech for $8.3B
Roche Buys Biotech for $8.3B
Jef Akst | Aug 27, 2014
The pharma giant strikes a deal to acquire InterMune, a Brisbane, California-based biotech with only one product—a treatment for a fatal lung disease.
Biotech Terminates IPO
Biotech Terminates IPO
Jyoti Madhusoodanan | Aug 15, 2014
The Israeli firm Vascular Biogenics withdrew its initial public offering after six days of trading. 
Scripps’s President Steps Down
Scripps’s President Steps Down
Kerry Grens | Jul 23, 2014
Following widespread disapproval among faculty members, Scripps’s Michael Marletta resigns his post.
AbbVie Buys Shire for $54 Billion
AbbVie Buys Shire for $54 Billion
Bob Grant | Jul 21, 2014
The massive pharma deal will create one of the 50 largest companies in the world, and will move AbbVie’s corporate tax headquarters from North Chicago to the U.K.